Hospital
Flambeau Hospital INC
Flambeau Hospital INC was paid $6.99M by Medicaid between Jan 2018 and Dec 2024, across 128 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
33Billing provider infoFLAMBEAU HOSPITAL INC
PARK FALLS, WI 54552
PARK FALLS, WI 54552
33aNPI1700963048assigned 11/01/2006
33bProvider typeCritical Access Hospital
28Total paid$6.99M
24GClaims125,059
24DCodes billed128
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Wisconsin
Rank by total paid#18 of 48
Median peer was paid$4.30M
This provider vs. median1.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official BRESSLER, KATHLEEN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,309 | $560K | |
| 2019 | 16,737 | $627K | |
| 2020 | 15,415 | $795K | |
| 2021 | 22,616 | $1.46M | |
| 2022 | 23,967 | $1.62M | |
| 2023 | 17,285 | $1.09M | |
| 2024incomplete | 15,730 | $834K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 6,446 | 5,048 | $1.51M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 15% | 4,882 | 3,442 | $1.04M |
| 96361 | Intravenous infusion, hydration; each additional hour | 11% | 1,123 | 755 | $756K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.3% | 2,887 | 1,939 | $583K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.7% | 1,895 | 1,680 | $468K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.2% | 1,577 | 1,360 | $430K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.9% | 1,545 | 1,351 | $340K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.3% | 889 | 664 | $300K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.7% | 1,049 | 863 | $189K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.5% | 604 | 567 | $103K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.4% | 475 | 405 | $97K |
| A0390 | Als mileage (per mile) | 1.4% | 166 | 149 | $95K |
116 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 3,448 | $93K |
| A0429 | Emergency ambulance ride, basic life support | 1.3% | 1,016 | $92K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,399 | $60K |
| 80053 | Comprehensive metabolic panel | <1% | 8,058 | $54K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 652 | $50K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 607 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,517 | $43K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,222 | $41K |
| A0425 | Ground mileage, per statute mile | <1% | 387 | $33K |
| A0427 | Emergency ambulance ride, advanced life support | <1% | 141 | $32K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 136 | $30K |
| 80061 | Lipid panel | <1% | 2,576 | $30K |
| A0434 | Specialty care transport (sct) | <1% | 62 | $30K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,146 | $30K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,889 | $26K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 1,086 | $25K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 871 | $24K |
| 87634 | <1% | 451 | $22K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 256 | $22K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 715 | $21K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,570 | $15K |
| 73630 | <1% | 297 | $15K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,525 | $14K |
| 84484 | <1% | 3,024 | $14K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 313 | $12K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,730 | $11K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 99 | $10K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 568 | $9K |
| 83605 | <1% | 2,075 | $9K | |
| 80050 | General health panel | <1% | 769 | $9K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,654 | $8K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,538 | $8K |
| 81001 | <1% | 4,048 | $8K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $8K |
| 83735 | <1% | 2,192 | $7K | |
| 83880 | <1% | 597 | $6K | |
| 82077 | <1% | 229 | $6K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,046 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 345 | $5K |
| 73562 | <1% | 138 | $5K | |
| 86140 | <1% | 1,877 | $5K | |
| 83690 | <1% | 1,289 | $5K | |
| 81025 | <1% | 662 | $5K | |
| 85610 | <1% | 1,880 | $5K | |
| G0380 | Level 1 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 30 | $5K |
| 84145 | <1% | 511 | $5K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 17 | $4K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 23 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 11,804 | $4K |
| 80306 | <1% | 238 | $3K | |
| A0380 | Bls mileage (per mile) | <1% | 120 | $3K |
| 97035 | <1% | 347 | $3K | |
| 87040 | <1% | 1,004 | $3K | |
| 73610 | <1% | 96 | $2K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 84 | $2K |
| 73130 | <1% | 45 | $2K | |
| 81003 | <1% | 551 | $2K | |
| 74018 | <1% | 179 | $2K | |
| 85379 | <1% | 400 | $2K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 37 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 56 | $2K |
| 87081 | <1% | 156 | $2K | |
| 97161 | <1% | 44 | $1K | |
| 73110 | <1% | 40 | $1K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,066 | $1K |
| 97162 | <1% | 43 | $1K | |
| 82728 | <1% | 79 | $957.44 | |
| 73030 | <1% | 27 | $921.09 | |
| 82962 | <1% | 677 | $727.12 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 25 | $588.42 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 29 | $585.19 |
| 87186 | <1% | 79 | $516.76 | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 31 | $491.97 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $471.38 |
| 84153 | <1% | 30 | $419.71 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 12 | $398.86 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 13 | $376.74 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 20 | $357.72 |
| 82150 | <1% | 96 | $317.35 | |
| 82803 | <1% | 31 | $299.04 | |
| 83540 | <1% | 49 | $274.29 | |
| 85652 | <1% | 99 | $262.21 | |
| 83550 | <1% | 48 | $234.78 | |
| 84460 | <1% | 58 | $178.73 | |
| 82310 | <1% | 82 | $178.48 | |
| 84075 | <1% | 60 | $168.03 | |
| 84450 | <1% | 56 | $162.09 | |
| 82040 | <1% | 57 | $160.66 | |
| 86618 | <1% | 12 | $158.40 | |
| 84520 | <1% | 81 | $132.25 | |
| 84155 | <1% | 56 | $114.42 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,697 | $97.28 |
| 85730 | <1% | 47 | $93.15 | |
| 87088 | <1% | 13 | $84.43 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,325 | $72.30 |
| 85027 | <1% | 15 | $60.21 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 735 | $41.22 |
| 82948 | <1% | 12 | $26.70 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,475 | $25.32 |
| 36592 | <1% | 18 | $24.35 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 265 | $24.26 |
| A9270 | Non-covered item or service | <1% | 1,583 | $17.22 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 95 | $8.33 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 46 | $3.22 |
| J3490 | Unclassified drugs | <1% | 129 | $1.37 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 41 | $0.84 |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 932 | $0.01 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 411 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 131 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 44 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 387 | $0.00 |
| 96376 | 0% | 148 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 13 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 94 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 14 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 27 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRESSLER, KATHLEEN (COO, AO)
Parent organizationMARSHFIELD CLINIC HEALTH SYSTEM INC
| Provider | Location | Paid |
|---|---|---|
| Lakeview Medical Center INC of Rice Lake | Rice Lake, WI | $9.98M |
| Memorial Hospital INC | Neillsville, WI | $4.01M |
| Lakeview Medical Center INC of Rice Lake | Rice Lake, WI | $2.24M |
| Lakeview Medical Center INC of Rice Lake | Rice Lake, WI | $1.64M |
| MCHS Hospitals INC | Stevens Point, WI | $906K |
| Dickinson County Healthcare System | Iron Mountain, MI | $564K |
| Memorial Hospital INC | Colby, WI | $477K |
| Memorial Hospital INC | Neillsville, WI | $457K |
| Flambeau Hospital INC | Park Falls, WI | $421K |
| Dickinson County Healthcare System | Marquette, MI | $108K |
| MCHS Hospitals INC | Stevens Point, WI | $100K |
| Flambeau Hospital INC | Phillips, WI | $85K |
| Lakeview Medical Center INC of Rice Lake | Hayward, WI | $62K |
| MCHS Hospitals, INC. | Plover, WI | $60K |
| Lakeview Medical Center INC of Rice Lake | Cumberland, WI | $49K |
| Memorial Hospital INC | Greenwood, WI | $26K |
| Marshfield Clinic INC | Marshfield, WI | $9K |
| MCHS Hospitals INC | Chippewa Falls, WI | $5K |
| MCHS Hospitals INC | Wausau, WI | $5K |
| Memorial Hospital INC | Stratford, WI | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.